Selected research
Market Analysis & Forecast
Global Voltaren Market Analysis and Forecast 2026-2032
Market perspective
The global Voltaren market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Voltaren is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Voltaren is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Voltaren is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Voltaren is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Voltaren include Endo Pharmaceuticals, Enovachem Pharmaceuticals, Hainan Quanxing Pharmaceutical, Iroko Pharmaceuticals, Jewim Pharmaceutical, Supor South Ocean, GSK and Novartis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Voltaren, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Voltaren, also provides the sales of main regions and countries. Of the upcoming market potential for Voltaren, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Voltaren sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Voltaren market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Voltaren sales, projected growth trends, production technology, application and end-user industry.
Voltaren Segment by Company
Endo Pharmaceuticals
Enovachem Pharmaceuticals
Hainan Quanxing Pharmaceutical
Iroko Pharmaceuticals
Jewim Pharmaceutical
Supor South Ocean
GSK
Novartis
Voltaren Segment by Type
Injection
Tablet
Spray
Gel
Capsule
Voltaren Segment by Application
Elderly
Adults
Voltaren Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Voltaren market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Voltaren and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Voltaren.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Voltaren in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Voltaren manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Voltaren sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Tablet
- Spray
- Gel
- Capsule
Applications
- Elderly
- Adults
Companies covered
- Endo Pharmaceuticals
- Enovachem Pharmaceuticals
- Hainan Quanxing Pharmaceutical
- Iroko Pharmaceuticals
- Jewim Pharmaceutical
- Supor South Ocean
- GSK
- Novartis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Voltaren Market by Type
- 1.2.1 Global Voltaren Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Injection
- 1.2.3 Tablet
- 1.2.4 Spray
- 1.2.5 Gel
- 1.2.6 Capsule
- 1.3 Voltaren Market by Application
- 1.3.1 Global Voltaren Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Elderly
- 1.3.3 Adults
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Voltaren Market Dynamics
- 2.1 Voltaren Industry Trends
- 2.2 Voltaren Industry Drivers
- 2.3 Voltaren Industry Opportunities and Challenges
- 2.4 Voltaren Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Voltaren Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Voltaren Revenue by Region
- 3.2.1 Global Voltaren Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Voltaren Revenue by Region (2021-2026)
- 3.2.3 Global Voltaren Revenue by Region (2027-2032)
- 3.2.4 Global Voltaren Revenue Market Share by Region (2021-2032)
- 3.3 Global Voltaren Sales Estimates and Forecasts 2021-2032
- 3.4 Global Voltaren Sales by Region
- 3.4.1 Global Voltaren Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Voltaren Sales by Region (2021-2026)
- 3.4.3 Global Voltaren Sales by Region (2027-2032)
- 3.4.4 Global Voltaren Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Voltaren Revenue by Manufacturers
- 4.1.1 Global Voltaren Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Voltaren Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Voltaren Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Voltaren Sales by Manufacturers
- 4.2.1 Global Voltaren Sales by Manufacturers (2021-2026)
- 4.2.2 Global Voltaren Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Voltaren Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Voltaren Sales Price by Manufacturers (2021-2026)
- 4.4 Global Voltaren Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Voltaren Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Voltaren Manufacturers, Product Type & Application
- 4.7 Global Voltaren Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Voltaren Market CR5 and HHI
- 4.8.2 2025 Voltaren Tier 1, Tier 2, and Tier 3
5 Voltaren Market by Type
- 5.1 Global Voltaren Revenue by Type
- 5.1.1 Global Voltaren Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Voltaren Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Voltaren Revenue Market Share by Type (2021-2032)
- 5.2 Global Voltaren Sales by Type
- 5.2.1 Global Voltaren Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Voltaren Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Voltaren Sales Market Share by Type (2021-2032)
- 5.3 Global Voltaren Price by Type
6 Voltaren Market by Application
- 6.1 Global Voltaren Revenue by Application
- 6.1.1 Global Voltaren Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Voltaren Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Voltaren Revenue Market Share by Application (2021-2032)
- 6.2 Global Voltaren Sales by Application
- 6.2.1 Global Voltaren Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Voltaren Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Voltaren Sales Market Share by Application (2021-2032)
- 6.3 Global Voltaren Price by Application
7 Company Profiles
- 7.1 Endo Pharmaceuticals
- 7.1.1 Endo Pharmaceuticals Company Information
- 7.1.2 Endo Pharmaceuticals Business Overview
- 7.1.3 Endo Pharmaceuticals Voltaren Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Endo Pharmaceuticals Voltaren Product Portfolio
- 7.1.5 Endo Pharmaceuticals Recent Developments
- 7.2 Enovachem Pharmaceuticals
- 7.2.1 Enovachem Pharmaceuticals Company Information
- 7.2.2 Enovachem Pharmaceuticals Business Overview
- 7.2.3 Enovachem Pharmaceuticals Voltaren Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Enovachem Pharmaceuticals Voltaren Product Portfolio
- 7.2.5 Enovachem Pharmaceuticals Recent Developments
- 7.3 Hainan Quanxing Pharmaceutical
- 7.3.1 Hainan Quanxing Pharmaceutical Company Information
- 7.3.2 Hainan Quanxing Pharmaceutical Business Overview
- 7.3.3 Hainan Quanxing Pharmaceutical Voltaren Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Hainan Quanxing Pharmaceutical Voltaren Product Portfolio
- 7.3.5 Hainan Quanxing Pharmaceutical Recent Developments
- 7.4 Iroko Pharmaceuticals
- 7.4.1 Iroko Pharmaceuticals Company Information
- 7.4.2 Iroko Pharmaceuticals Business Overview
- 7.4.3 Iroko Pharmaceuticals Voltaren Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Iroko Pharmaceuticals Voltaren Product Portfolio
- 7.4.5 Iroko Pharmaceuticals Recent Developments
- 7.5 Jewim Pharmaceutical
- 7.5.1 Jewim Pharmaceutical Company Information
- 7.5.2 Jewim Pharmaceutical Business Overview
- 7.5.3 Jewim Pharmaceutical Voltaren Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Jewim Pharmaceutical Voltaren Product Portfolio
- 7.5.5 Jewim Pharmaceutical Recent Developments
- 7.6 Supor South Ocean
- 7.6.1 Supor South Ocean Company Information
- 7.6.2 Supor South Ocean Business Overview
- 7.6.3 Supor South Ocean Voltaren Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Supor South Ocean Voltaren Product Portfolio
- 7.6.5 Supor South Ocean Recent Developments
- 7.7 GSK
- 7.7.1 GSK Company Information
- 7.7.2 GSK Business Overview
- 7.7.3 GSK Voltaren Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 GSK Voltaren Product Portfolio
- 7.7.5 GSK Recent Developments
- 7.8 Novartis
- 7.8.1 Novartis Company Information
- 7.8.2 Novartis Business Overview
- 7.8.3 Novartis Voltaren Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Novartis Voltaren Product Portfolio
- 7.8.5 Novartis Recent Developments
8 North America
- 8.1 North America Voltaren Market Size by Type
- 8.1.1 North America Voltaren Revenue by Type (2021-2032)
- 8.1.2 North America Voltaren Sales by Type (2021-2032)
- 8.1.3 North America Voltaren Price by Type (2021-2032)
- 8.2 North America Voltaren Market Size by Application
- 8.2.1 North America Voltaren Revenue by Application (2021-2032)
- 8.2.2 North America Voltaren Sales by Application (2021-2032)
- 8.2.3 North America Voltaren Price by Application (2021-2032)
- 8.3 North America Voltaren Market Size by Country
- 8.3.1 North America Voltaren Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Voltaren Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Voltaren Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Voltaren Market Size by Type
- 9.1.1 Europe Voltaren Revenue by Type (2021-2032)
- 9.1.2 Europe Voltaren Sales by Type (2021-2032)
- 9.1.3 Europe Voltaren Price by Type (2021-2032)
- 9.2 Europe Voltaren Market Size by Application
- 9.2.1 Europe Voltaren Revenue by Application (2021-2032)
- 9.2.2 Europe Voltaren Sales by Application (2021-2032)
- 9.2.3 Europe Voltaren Price by Application (2021-2032)
- 9.3 Europe Voltaren Market Size by Country
- 9.3.1 Europe Voltaren Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Voltaren Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Voltaren Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Voltaren Market Size by Type
- 10.1.1 China Voltaren Revenue by Type (2021-2032)
- 10.1.2 China Voltaren Sales by Type (2021-2032)
- 10.1.3 China Voltaren Price by Type (2021-2032)
- 10.2 China Voltaren Market Size by Application
- 10.2.1 China Voltaren Revenue by Application (2021-2032)
- 10.2.2 China Voltaren Sales by Application (2021-2032)
- 10.2.3 China Voltaren Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Voltaren Market Size by Type
- 11.1.1 Asia Voltaren Revenue by Type (2021-2032)
- 11.1.2 Asia Voltaren Sales by Type (2021-2032)
- 11.1.3 Asia Voltaren Price by Type (2021-2032)
- 11.2 Asia Voltaren Market Size by Application
- 11.2.1 Asia Voltaren Revenue by Application (2021-2032)
- 11.2.2 Asia Voltaren Sales by Application (2021-2032)
- 11.2.3 Asia Voltaren Price by Application (2021-2032)
- 11.3 Asia Voltaren Market Size by Country
- 11.3.1 Asia Voltaren Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Voltaren Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Voltaren Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Voltaren Market Size by Type
- 12.1.1 SAMEA Voltaren Revenue by Type (2021-2032)
- 12.1.2 SAMEA Voltaren Sales by Type (2021-2032)
- 12.1.3 SAMEA Voltaren Price by Type (2021-2032)
- 12.2 SAMEA Voltaren Market Size by Application
- 12.2.1 SAMEA Voltaren Revenue by Application (2021-2032)
- 12.2.2 SAMEA Voltaren Sales by Application (2021-2032)
- 12.2.3 SAMEA Voltaren Price by Application (2021-2032)
- 12.3 SAMEA Voltaren Market Size by Country
- 12.3.1 SAMEA Voltaren Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Voltaren Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Voltaren Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Voltaren Value Chain Analysis
- 13.1.1 Voltaren Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Voltaren Production Mode & Process
- 13.2 Voltaren Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Voltaren Distributors
- 13.2.3 Voltaren Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst